People with glioblastoma are being deprived of the best chance of survival: easy access to clinical trials and off-label treatments, according to a survey of 162 patients and caregivers conducted by OurBrainBank.
Last week’s issue of The Cancer Letter included an obituary that the entire staff at The Cancer Letter had been dreading for years: Abdallah Abou Zahr, an oncologist at Roger Maris Cancer Center in Fargo, ND, died Jan. 23 of a liposarcoma after a five-year battle with the disease.
